Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus intra-patient variability and immune memory in kidney transplant recipients
NL-OMON45414Not yet recruiting
- Sponsor
- Inwendige Geneeskunde - Nefrologie en Transplantatie
- Start
- Feb 2017
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tacrolimus in kidney transplant immunosuppression (2 cohorts), sponsored by Inwendige Geneeskunde - Nefrologie en Transplantatie. Primary endpoint: Donor-specific T-cell and B-cell memory function. Planned start Feb 2017; status: not yet recruiting.
02
Drugs
tacrolimus
03
Conditions
kidney transplant immunosuppression
Beyond the preview
Go deeper on NL-OMON45414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45414.